Target intelligence / Profile preview

novel atrophin-1 superfamily protein pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

This gene entry, "novel atrophin-1 superfamily protein pseudogene" (ENSG00000285228), encodes a pseudogene related in sequence to the atrophin-1 superfamily of proteins but does not produce a functional protein. Pseudogenes are genomic elements that usually arise from duplication or retrotransposition events and have lost coding potential due to disabling mutations. Most pseudogenes, including this one, are considered non-functional "genomic fossils," although growing evidence suggests that some pseudogenes may exert regulatory roles at the RNA level, potentially via small RNA production or acting as competitive endogenous RNAs (ceRNAs). However, there is no evidence that this specific pseudogene is functional, relevant to disease, or serves as a drug target. Therefore, it is not considered a therapeutic target, and there is nothing to suggest it encodes a receptor, transporter, enzyme, or structurally relevant molecule for pharmacology. Key points: - This entry is a pseudogene, not a true protein-coding gene or therapeutic target. - There is no evidence it has a functional role or druggability. - It is incorrect to categorize it as a receptor or target for drugs based on current understanding of its nature and the available data.

Other names
ENSG00000285228novel atrophin-1 superfamily protein pseudogene
02

Biological functions

Possible regulatory RNA molecule (inferred from pseudogene biology generally)No protein-coding function
03

Disease associations

Other (Pseudogenes can be dysregulated in disease and may have some regulatory roles in cancer or other conditions, but this is context-specific and not established for this specific pseudogene)

Beyond the preview

Go deeper on novel atrophin-1 superfamily protein pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel atrophin-1 superfamily protein pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call